Co-Authors
This is a "connection" page, showing publications co-authored by Andrea Isidori and Andrea Lenzi.
Connection Strength
4.109
-
COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency. J Endocrinol Invest. 2020 Aug; 43(8):1141-1147.
Score: 0.879
-
Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial. Lancet Diabetes Endocrinol. 2018 03; 6(3):173-185.
Score: 0.745
-
Targeting the NO-cGMP-PDE5 pathway in COVID-19 infection. The DEDALO project. Andrology. 2021 01; 9(1):33-38.
Score: 0.223
-
The Italian Endo-COVID-19. Our response to the emergency. J Endocrinol Invest. 2020 Jul; 43(7):1039-1041.
Score: 0.220
-
Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection. Lancet Diabetes Endocrinol. 2020 06; 8(6):472-473.
Score: 0.220
-
Pegvisomant Improves Glucose Metabolism in Acromegaly: A Meta-Analysis of Prospective Interventional Studies. J Clin Endocrinol Metab. 2019 07 01; 104(7):2892-2902.
Score: 0.208
-
PDE5 Inhibition Stimulates Tie2-Expressing Monocytes and Angiopoietin-1 Restoring Angiogenic Homeostasis in Diabetes. J Clin Endocrinol Metab. 2019 07 01; 104(7):2623-2636.
Score: 0.208
-
Circadian Rhythm of Glucocorticoid Administration Entrains Clock Genes in Immune Cells: A DREAM Trial Ancillary Study. J Clin Endocrinol Metab. 2018 08 01; 103(8):2998-3009.
Score: 0.195
-
The CATCH checklist to investigate adult-onset hypogonadism. Andrology. 2018 09; 6(5):665-679.
Score: 0.193
-
Somatostatin Analogs and Glucose Metabolism in Acromegaly: A Meta-analysis of Prospective Interventional Studies. J Clin Endocrinol Metab. 2018 Mar 23.
Score: 0.190
-
Cardiovascular features of possible autonomous cortisol secretion in patients with adrenal incidentalomas. Eur J Endocrinol. 2018 May; 178(5):501-511.
Score: 0.189
-
Deregulation of the growth hormone/insulin-like growth factor-1 axis in adults with cystic fibrosis. J Endocrinol Invest. 2018 May; 41(5):591-596.
Score: 0.185
-
SARS-CoV-2 infection, male fertility and sperm cryopreservation: a position statement of the Italian Society of Andrology and Sexual Medicine (SIAMS) (Società Italiana di Andrologia e Medicina della Sessualità ). J Endocrinol Invest. 2020 Aug; 43(8):1153-1157.
Score: 0.055
-
Clinical presentation, management and follow-up of 83 patients with Leydig cell tumors of the testis: a prospective case-cohort study. Hum Reprod. 2019 08 01; 34(8):1389-1403.
Score: 0.052
-
Chronic phosphodiesterase type 5 inhibition has beneficial effects on subcutaneous adipose tissue plasticity in type 2 diabetic mice. J Cell Physiol. 2018 11; 233(11):8411-8417.
Score: 0.048
-
Critical role of phosphodiesterase 2A in mouse congenital heart defects. Cardiovasc Res. 2018 05 01; 114(6):830-845.
Score: 0.048
-
Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM). J Endocrinol Invest. 2018 Jan; 41(1):3-19.
Score: 0.046
-
Identification of murine phosphodiesterase 5A isoforms and their functional characterization in HL-1 cardiac cell line. J Cell Physiol. 2018 Jan; 233(1):325-337.
Score: 0.045
-
Profiling of selenium absorption and accumulation in healthy subjects after prolonged L-selenomethionine supplementation. J Endocrinol Invest. 2017 Nov; 40(11):1183-1190.
Score: 0.044
-
Phosphodiesterase-5 inhibition preserves renal hemodynamics and function in mice with diabetic kidney disease by modulating miR-22 and BMP7. Sci Rep. 2017 03 15; 7:44584.
Score: 0.044
-
Anaplastic thyroid carcinoma and foscarnet use in a multitarget treatment documented by 18F-FDG PET/CT: A case report. Medicine (Baltimore). 2017 Feb; 96(6):e5621.
Score: 0.044
-
Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study. J Sex Med. 2010 Oct; 7(10):3495-503.
Score: 0.028